您的位置: 首页 > 农业专利 > 详情页

LYOPHILIZED FORMULATION OF HGF
专利权人:
LTD.;EISAI R&D MANAGEMENT CO.
发明人:
Ryo Ohori,Kanta Horie
申请号:
US15305049
公开号:
US20170189487A1
申请日:
2015.04.24
申请国别(地区):
US
年份:
2017
代理人:
摘要:
An object of the present invention is to provide a lyophilized formulation having improved storage stability of hepatic growth factor compared to conventional lyophilized formulations.The present invention provides a lyophilized formulation comprising (1) a hepatic growth factor, (2) trehalose and (3) one or more compounds selected from the group consisting of arginine, histidine, lysine, meglumine, glutamic acid, aspartic acid, proline, creatine, creatinine, tris(hydroxymethyl)aminomethane, and pharmaceutically acceptable salts thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充